These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27755511)

  • 1. In brief: Hepatitis B reactivation with direct-acting antiviral drugs for hepatitis C.
    Med Lett Drugs Ther; 2016 Oct; 58(1506):140. PubMed ID: 27755511
    [No Abstract]   [Full Text] [Related]  

  • 2. New Black Box Warning for Direct-Acting Antivirals for HCV.
    Aschenbrenner DS
    Am J Nurs; 2017 Feb; 117(2):21. PubMed ID: 28125487
    [No Abstract]   [Full Text] [Related]  

  • 3. New warning on hepatitis C drugs.
    Collier R
    CMAJ; 2017 Jan; 189(3):E120-E121. PubMed ID: 27993921
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hepatitis B and C -- current standards].
    Zeuzem S
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
    [No Abstract]   [Full Text] [Related]  

  • 5. In brief: Hepatic injury with hepatitis C drugs.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):156. PubMed ID: 26529136
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C testing and treatment: hope for the future?
    Reynolds A
    Posit Aware; 2014; 26(1):25-7. PubMed ID: 24847576
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
    Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon therapy for hepatitis B and C].
    Iino S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent research in HIV infection, part 2.
    Boyle BA
    AIDS Read; 2002 Dec; 12(12):524-6, 539. PubMed ID: 12518718
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulators deny access to experimental hepatitis C drug.
    Hillson G
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):31-2. PubMed ID: 14719494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: necessity of antiviral prophylaxis.
    Zhang B; Wang J; Xu W; Wang L; Ni W
    Onkologie; 2010; 33(10):537-9. PubMed ID: 20926902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA notifications. FDA revises Baraclude labeling for HIV patients.
    AIDS Alert; 2007 Sep; 22(9):103-4. PubMed ID: 18415955
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge.
    Sterling RK
    Am J Gastroenterol; 2003 Oct; 98(10):2130-4. PubMed ID: 14572556
    [No Abstract]   [Full Text] [Related]  

  • 16. Studying new drugs for HCV. Excerpts from the FDA hearing.
    Huff B
    GMHC Treat Issues; 2006; 20(8-12):11-4. PubMed ID: 17569164
    [No Abstract]   [Full Text] [Related]  

  • 17. Herpes virus reactivation during and after direct-acting antiviral therapy for hepatitis C virus infection.
    Yokoo T; Tsuchiya A; Sugitani S; Terai S
    Dig Liver Dis; 2017 Apr; 49(4):453-454. PubMed ID: 28237297
    [No Abstract]   [Full Text] [Related]  

  • 18. The new era of hepatitis C treatment: still the tip of the iceberg?
    Gasbarrini A; Ponziani FR; Annichiarico BE; Siciliano M; Craxì A
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2271-4. PubMed ID: 24065217
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
    Boyle BA
    AIDS Read; 2001 Aug; 11(8):387-90, 397. PubMed ID: 11570261
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in and the future of treatments for hepatitis C.
    Cheng R; Tu T; Shackel N; McCaughan GW
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):633-47. PubMed ID: 24846594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.